Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Venous Thrombosis 1Venous Thromboembolism 1Thrombosis 1Sarcoma, Alveolar Soft Part 1Pulmonary Embolism 1Prostatic Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1

Interventions

pazopanib 2cediranib 2Sunitinib 2Ifosfamide 2Doxorubicin 2sargramostim 1romidepsin 1pembrolizumab 1indolepropanol phosphate 1cabozantinib 1atropine sulfate-diphenoxylate hydrochloride drug combination 1Watchful Waiting 1Warfarin 1Vitamin B 6 1Thyroxine 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Radiation 1Pyridoxine 1Promethazine 1Prochlorperazine 1Polymerase Chain Reaction 1Petrolatum 1Observation 1Neoadjuvant Therapy 1Lorazepam 1Loperamide 1HhAntag691 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sarcoma, Alveolar Soft Part × Warfarin × Clear all
NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
34 enrolled 22 charts
Sarcoma

Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡